GEN Exclusives

More »

GEN News Highlights

More »
Nov 13, 2007

Fluorotechnics Fortifies Electrophoresis Business with Purchase of ETC Elektrophorese-Technik

  • To buttress its services and position in the electrophoresis market, Fluorotechnics plans to acquire ETC Elektrophorese-Technik in a stock-for-stock agreement.

    Fluorotechnics focuses on the development of fluorescent research tools for proteomics, cell biology, and biochemistry research. ETC Elektrophorese-Technik will add high-end electrophoresis consumables and equipment used for diagnostics, quality control, and species identification.

    The integrated company will retain its manufacturing bases in Sydney and Kirchentellinsfurt, Germany.

    “This acquisition will allow us to cross-sell products to existing customers and to address new markets utilizing our joint expertise,” remarks Duncan Veal, CEO of Fluorotechnics. The company’s expanding sales and marketing team, and the potential of its products, Veal adds, “means that we are well-positioned for strong growth.”


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

New NIH Budget Proposal Leaves Many Confused and Unsettled

Do you think that using the so-called “mandatory budget funds” to pay for the proposed $825 million increase, as well as $1 billion of the NIH’s existing budget is a good idea?

More »